Heng-Juei Hsu

Heng-Juei Hsu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2024 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
CWChia-En Wong
Chia-En Wong
YCYu Chang
Yu Chang
PCPei-Wen Chen
Pei-Wen Chen
YHYan-Ta Huang
Yan-Ta Huang
YCYu-Cheng Chang
Yu-Cheng Chang
JLJung-Shun Lee
Jung-Shun Lee

13 November 2023 in Neurology International
Verified
Journal Article
Open access
PDF file
PLPo-Hsuan Lee
Po-Hsuan Lee
HHHeng-Juei Hsu
Heng-Juei Hsu
CTChih-Hao Tien
Chih-Hao Tien
CHChi-Chen Huang
Chi-Chen Huang
CHChih-Yuan Huang
Chih-Yuan Huang
JLJung-Shun Lee
Jung-Shun Lee
The clip-induced spinal cord injury (SCI) rat model is pivotal in preclinical SCI research. However, the literature exhibits variability in compression duration and limited attention to clip deformation-related loss of closure force. We aimed to investigate the impact of compression duration on SCI severity and the influence of clip deformation on closure force. Rats received T10-level clip-induced SCI with durations of 1, 5, 10, 20, and 30 s, and a separate group underwent T10 transection. Outcomes included functional, histological, electrophysiological assessments, and inflammatory cytokine analysis. A tactile pressure mapping system quantified clip closure force after open–close cycles. Our results showed a positive correlation between compression duration and the severity of functional, histological, and electrophysiological deficits. Remarkably, even a brief 1-s compression caused significant deficits comparable to moderate-to-severe SCI. SSEP waveforms were abolished with durations over 20 s. Decreased clip closure force appeared after five open–close cycles. This study offers critical insights into regulating SCI severity in rat models, aiding researchers. Understanding compression duration and clip fatigue is essential for experiment design and interpretation using the clip-induced SCI model.

25 March 2026 in Neuroradiology
Verified
Journal Article
Open access
PDF file
YCYu-Han Chin
Yu-Han Chin
HHHeng-Juei Hsu
Heng-Juei Hsu
MCMing-Tsung Chuang
Ming-Tsung Chuang
CHChih-Yuan Huang
Chih-Yuan Huang
CTChih-Hao Tien
Chih-Hao Tien
CWChia-En Wong
Chia-En Wong
Objective The superficial cerebral venous system demonstrates considerable anatomical variability. The inferior anastomotic vein, or vein of Labbé (VOL), is a key anastomotic channel between the superficial middle cerebral veins and the transverse sinus. However, the morphological characteristics of the VOL remain inadequately defined, particularly in East Asian populations. This study aimed to systematically analyze the angioarchitecture of the VOL. Methods The VOL was evaluated using three-dimensional (3D) reconstructions derived from gadolinium-enhanced 3D T1-weighted turbo spin-echo sequences and validated against digital subtraction angiography (DSA). Key anatomical parameters – including number, diameter, lateralization, drainage entry points, and the relationship with the superior anastomotic vein – were assessed in 200 cerebral hemispheres from 100 healthy individuals (50 males, 50 females). Results In the validation cohort (n = 20 hemispheres), 3D MRA demonstrated high concordance with DSA in identifying VOL anatomy and diameter. Among all 200 hemispheres analyzed, VOL duplication was identified in 2% and complete absence in 0.5%. The VOL drained into the transverse sinus in 61.3% of cases, into the SDA in 32.7%, and into the superior petrosal sinus in 4%. A lateralized drainage pattern was observed, with the VOL being more prominent than the superior anastomotic vein on the left hemisphere, whereas the superior anastomotic vein predominated on the right hemispheres (p = 0.022). Conclusions This study represents the largest imaging-based analysis of VOL anatomy in an East Asian population. The VOL exhibits substantial interindividual variability in number, drainage pattern, and lateralization. Detailed knowledge of these anatomical nuances is crucial to minimize risk of venous infarction and enhance neurosurgical outcomes.

3 November 2026 in International Journal of Surgery
Verified
Journal Article
Open access
CWChia-En Wong
Chia-En Wong
PLPo-Hsuan Lee
Po-Hsuan Lee
PCPei-Wen Chen
Pei-Wen Chen
SCShu-Yu Chen
Shu-Yu Chen
SWShih-Ying Wu
Shih-Ying Wu
JLJung-Shun Lee
Jung-Shun Lee
Background: Brain metastasis (BrM) from non-small cell lung cancer (NSCLC) is driven by a profoundly immunosuppressive tumor microenvironment (TME) characterized by M2-polarized tumor-associated macrophages (TAMs) and microglia, T-cell exhaustion, and programmed cell death (PD) signaling, which jointly limit the efficacy of current therapies. Transcranial electric field stimulation (EFS) has emerged as a potential neuromodulatory strategy to regulate the TME of brain cancers. Nonetheless, its impact on the BrM TME, optimal stimulation parameters, and functional mechanisms remain unclear. Materials and methods: This preclinical investigation utilized an integrated translational platform comprising patient-derived NSCLC BrM tumor organoids ( n = 8), an immunocompetent syngeneic Lewis lung cancer (LLC) BrM mouse model, and in vitro organotypic brain slice cultures. Low-frequency EFS at 2–15 and 75 Hz was applied, and its efficacy was compared with tumor-treating fields (TTF; 150 kHz) and sham treatment. TME phenotypes were characterized by immunofluorescence, flow cytometry, Western blotting, and enzyme-linked immunosorbent assay (ELISA). Mechanistic studies were conducted in TAMs using calcium chelation, ion channel blockade, and protein kinase C (PKC) inhibition. Results: Among all EFS regimens tested, 75 Hz EFS significantly reduced BrM bioluminescence, tumor cross-sectional area (a 56% reduction vs. controls), and Ki-67 proliferation index, and prolonged survival in LLC BrM mice, whereas 2–15 Hz EFS had minimal effect and TTF showed only modest tumor control. 75 Hz EFS shifted TAMs from an M2-like CD206 + phenotype to an M1-like inducible nitric oxide synthase (iNOS)⁺/CD86⁺ phenotype, increased IL-1β and tumor necrosis factor (TNF)-α, and suppressed Janus kinase (JAK)2–signal transducer and activator of transcription (STAT3), IL-6, IL-10, and transforming growth factor (TGF)-β. It also reduced PD-1⁺ CD8⁺ exhausted T cells and PD-L1 expression in the BrM TME. These effects were recapitulated in patient-derived BrM tumor organoids and BrM-conditioned macrophage and microglia cultures, and were abrogated by calcium chelation, PKCα/β inhibition, or systemic dexamethasone. Conclusion: In this preclinical investigation, low-frequency transcranial EFS at 75 Hz represents a promising neuro-immunomodulatory strategy that reprograms the NSCLC BrM TME, restores anti-tumor immunity, and restrains tumor progression. Further clinical trials are required to validate the efficacy of low-frequency transcranial EFS in NSCLC BrM.